Are you struggling with infertility? Are you looking for a way to have a baby? In vitro fertilization (IVF) may be the answer for you. IVF is a procedure in which eggs are fertilized by sperm outside the body. The resulting embryos are then implanted into the uterus. IVF can be used to treat a variety of fertility problems. The IVF market in China is expected to grow from US$ 1.5 billion in 2020 to US$ 2.8 billion by 2025, at a CAGR of 13.0%. The growth of the IVF market in China is driven by factors such as the increasing prevalence of infertility, the growing number of women opting for IVF treatment, and the availability of government funding for IVF treatment. If you are struggling with infertility, don't hesitate to contact a fertility specialist to learn more about IVF and other fertility treatments.

China In Vitro Fertilization market will be US$ 2.8 Billion by 2025

In vitro fertilization (IVF) is a process of fertilization where an egg is combined with sperm outside the body, in vitro. The process involves monitoring and stimulating a woman’s ovulatory process, removing an ovum or ova (egg or eggs) from the woman’s ovaries and letting sperm fertilize them in a liquid in a laboratory.

The first successful birth of a “test-tube baby”, Louise Brown, occurred in 1978. Since then, IVF and other similar techniques have allowed millions of women to have children that otherwise would not have been born.

The global in vitro fertilization market was worth US$ 2.2 Billion in 2019. The market is further projected to reach a value of US$ 2.8 Billion by 2025, growing at a CAGR of 5.3% during 2020-2025.

Rising trend of delayed childbearing is a key factor driving the growth of the market. According to the National Vital Statistics Reports released by the Centers for Disease Control and Prevention (CDC), the number of births in the United States declined in 2018 for the fourth consecutive year. The general fertility rate in 2018 was 59.1 births per 1,000 women aged 15–44 years, down 2% from 2017. The total fertility rate was 1,728.5 births per 1,000 women in 2018, which was also down 2% from 2017.

In addition, the report stated that the number of births in 2018 was lower than the number of births in any year since 1986. The number of births has been declining since the peak in 2007. The total fertility rate has also been declining since 2007, and in 2018, it was at the lowest level in more than 30 years. Thus, the declining trend in fertility rates is expected to boost the growth of the in vitro fertilization market during the forecast period.

Some of the major players operating in the in vitro fertilization market are Ovascience, Inc., CooperSurgical, Inc., Vitrolife AB, Esco Micro Pte. Ltd., Irvine Scientific, and Thermo Fisher Scientific, Inc.


Renub Research is a leading Management Consultancy and Market Research Company. We have more than 10 years of experience in Research, Survey and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.